Advances in Pseudomonas aeruginosa Biofilm Control
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Biofilm".
Deadline for manuscript submissions: 15 June 2024 | Viewed by 878
Special Issue Editors
Interests: biofilm formation; cystic fibrosis; lung infections; antibiotic resistance; antimicrobial compounds; Pseudomonas aeruginosa
Special Issues, Collections and Topics in MDPI journals
Interests: biofilm formation; cystic fibrosis; lung infections; probiotics; antibiotic resistance; antimicrobial compounds; Pseudomonas aeruginosa; Stenotrophomonas maltophilia; bacterial pathogenesis; microbial cooperation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Pseudomonas aeruginosa was recently recognized as one of the most life-threatening bacteria and listed as a priority pathogen for research and development of new antibiotics by the WHO. Common antibiotics exhibit limited efficacy due to bacterial adaptability and intrinsic antibiotic resistance. Additionally, treatment is hindered by the P. aeruginosa ability to form biofilms which protect them from antibiotics, disinfectants, and host immunity, conferring the capacity for colonization and long-term persistence. Indeed, highly structured biofilms are observed in patients with chronic infections, resulting in high healthcare and economic consequences. Therefore, it is needed to develop therapeutic strategies as an alternative to traditional antibiotics, expected to disarm and eradicate P. aeruginosa.
Making a considerable contribution to the scientific community, this Special Issue aims to collect original research articles, short communications, reviews, and mini-reviews on all aspects of P. aeruginosa biofilm control and prevention strategies, thus providing a platform for researchers interested in sharing their recent results. Studies providing new insights into innovative therapeutic strategies (e.g., antimicrobial peptides, bacteriophages, natural products, nanoparticles, nanocarriers, EPS and QS inhibitors, photodynamic and photothermal strategies) to counteract biofilm formation and established (mature) biofilms in P. aeruginosa will be considered for publication.
Prof. Dr. Giovanni Di Bonaventura
Dr. Arianna Pompilio
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Pseudomonas aeruginosa
- biofilm control
- antibiofilm strategies
- antibiotic resistance
- chronic infections
- wound infections
- lung infections
